182 related articles for article (PubMed ID: 25706791)
1. Simultaneous (18)F-FDOPA PET/CT-guided biopsy and radiofrequency ablation of recurrent neuroendocrine hepatic metastasis: further step toward a theranostic approach.
Imperiale A; Garnon J; Bachellier P; Gangi A; Namer IJ
Clin Nucl Med; 2015 Jun; 40(6):e334-5. PubMed ID: 25706791
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience.
Cazzato RL; Garnon J; Ramamurthy N; Tsoumakidou G; Imperiale A; Namer IJ; Bachellier P; Caudrelier J; Rao P; Koch G; Gangi A
Cardiovasc Intervent Radiol; 2016 Sep; 39(9):1315-21. PubMed ID: 27048487
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
[TBL] [Abstract][Full Text] [Related]
4. Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation.
Imperiale A; Rust E; Boulanger C; Roedlich MN; Ollier JC; Schneegans O
Clin Nucl Med; 2012 Aug; 37(8):e206-8. PubMed ID: 22785529
[TBL] [Abstract][Full Text] [Related]
5. The Added Diagnostic Value of
Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A
J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002
[TBL] [Abstract][Full Text] [Related]
6. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Santhanam P; Taïeb D
Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
[TBL] [Abstract][Full Text] [Related]
7. Limited role of carbidopa-assisted
Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
[TBL] [Abstract][Full Text] [Related]
8. Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors.
Chen W; Zhuang H; Cheng G; Torigian DA; Alavi A
Ann Nucl Med; 2013 Jan; 27(1):58-64. PubMed ID: 23054830
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT in evaluation of radiofrequency ablation of liver metastasis.
Thulkar S; Chawla M; Sharma P; Malhotra A; Kumar R
Clin Nucl Med; 2012 May; 37(5):498-501. PubMed ID: 22475904
[TBL] [Abstract][Full Text] [Related]
10. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
[TBL] [Abstract][Full Text] [Related]
11. Carbidopa-assisted
Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
[TBL] [Abstract][Full Text] [Related]
12. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
13. 11C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastases.
Norlén O; Nilsson A; Krause J; Stålberg P; Hellman P; Sundin A
Nucl Med Biol; 2012 Aug; 39(6):883-90. PubMed ID: 22381780
[TBL] [Abstract][Full Text] [Related]
14. Best sensitivity of
Testart Dardel N; Montravers F; Triviño-Ibañez E; Gauthé M; Houry S; Talbot JN
Rev Esp Med Nucl Imagen Mol; 2016; 35(6):402-405. PubMed ID: 27246293
[TBL] [Abstract][Full Text] [Related]
15. 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
Minn H; Kemppainen J; Kauhanen S; Forsback S; Seppänen M
PET Clin; 2014 Jan; 9(1):27-36. PubMed ID: 25029931
[TBL] [Abstract][Full Text] [Related]
16. Epiglottic Squamous Cell Carcinoma Showing Unexpected 18F-FDOPA Uptake on PET/CT Investigation.
Dietemann S; Debry C; Onea A; Namer IJ; Imperiale A
Clin Nucl Med; 2015 Jul; 40(7):e370-1. PubMed ID: 26018705
[TBL] [Abstract][Full Text] [Related]
17. Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Becherer A; Szabó M; Karanikas G; Wunderbaldinger P; Angelberger P; Raderer M; Kurtaran A; Dudczak R; Kletter K
J Nucl Med; 2004 Jul; 45(7):1161-7. PubMed ID: 15235062
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
Weisbrod AB; Kitano M; Gesuwan K; Millo C; Herscovitch P; Nilubol N; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2012 Apr; 97(4):E613-7. PubMed ID: 22259055
[TBL] [Abstract][Full Text] [Related]
19. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
[TBL] [Abstract][Full Text] [Related]
20. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]